STATE OF WISCONSIN
CONTROLLED SUBSTANCES BOARD
---------------------------------------------------------------------------------------------------------------------
IN THE MATTER OF RULE-MAKING : AFFIRMATIVE ACTION
PROCEEDINGS BEFORE THE : ORDER OF THE
CONTROLLED SUBSTANCES BOARD : CONTROLLED SUBSTANCES BOARD
---------------------------------------------------------------------------------------------------------------------
FINDINGS
1. On May 21, 2009, the Department of Justice, Drug Enforcement Administration published its final rule in the Federal Register listing Lacosamide into schedule V of the federal Controlled Substances Act. The scheduling action is effective June 22, 2009.
2. The Controlled Substances Board did not receive an objection to similarly listing Lacosamide as a schedule V under ch. 961, Stats. within 30 days of the date of publication in the federal register of the final order listing Lacosamide as a schedule V controlled substance. 3. The Controlled Substances Board will promulgate a final rule, without making the determinations or findings required by ss. 961.11(1), (1m), (1r) and (2) or s. 961.21 and omitting the notice of proposed rulemaking, listing Lacosamide as a schedule V controlled substance. ORDER
Pursuant to s. 961.11(4), Stats., the Controlled Substances Board by affirmative action similarly treats Lacosamide under chapter 961, Stats. by creating the following: CSB 2.88 Addition of Lacosamide to schedule V. Section 961.22 (10), Stats., is created to read:
961.22 (10) Lacosamide.
This order shall take effect upon publication in the Administrative Register. The order expires upon promulgation of a final rule.Dated 7/9/2021 _______________________
Doug Englebert, Chair
Controlled Substances Board
